RANDOX ECSTASY (MDMA) ASSAY— 510(k) K092275

Substantially Equivalent

Randox Laboratories, Ltd.

FDA 510(k) clearance K092275 for RANDOX ECSTASY (MDMA) ASSAY, Substantially Equivalent on 2011-03-01. Applicant: Randox Laboratories, Ltd..

Clearance details

Applicant: Randox Laboratories, Ltd.
Product code: Code DKZ
Advisory panel: Clinical Toxicology
Date received: 2009-07-28
Decision date: 2011-03-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Crumlin, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.